BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 27466953)

  • 21. Prediction of MHC-binding peptides of flexible lengths from sequence-derived structural and physicochemical properties.
    Cui J; Han LY; Lin HH; Zhang HL; Tang ZQ; Zheng CJ; Cao ZW; Chen YZ
    Mol Immunol; 2007 Feb; 44(5):866-77. PubMed ID: 16806474
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Shift-invariant adaptive double threading: learning MHC II-peptide binding.
    Zaitlen N; Reyes-Gomez M; Heckerman D; Jojic N
    J Comput Biol; 2008 Sep; 15(7):927-42. PubMed ID: 18771399
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prediction of peptide-MHC binding using profiles.
    Reche PA; Reinherz EL
    Methods Mol Biol; 2007; 409():185-200. PubMed ID: 18450001
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Structure-based identification of MHC binding peptides: Benchmarking of prediction accuracy.
    Kumar N; Mohanty D
    Mol Biosyst; 2010 Dec; 6(12):2508-20. PubMed ID: 20953500
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of MHC class II binding peptides: microarray and soluble MHC class II molecules.
    Gaseitsiwe S; Maeurer MJ
    Methods Mol Biol; 2009; 524():417-26. PubMed ID: 19377962
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Truncation variants of peptides isolated from MHC class II molecules suggest sequence motifs.
    Rudensky AYu ; Preston-Hurlburt P; al-Ramadi BK; Rothbard J; Janeway CA
    Nature; 1992 Oct; 359(6394):429-31. PubMed ID: 1328884
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Use of global amino acid replacements to define the requirements for MHC binding and T cell recognition of moth cytochrome c (93-103).
    Reay PA; Kantor RM; Davis MM
    J Immunol; 1994 Apr; 152(8):3946-57. PubMed ID: 7511662
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular analysis of the same HIV peptide functionally binding to both a class I and a class II MHC molecule.
    Takeshita T; Takahashi H; Kozlowski S; Ahlers JD; Pendleton CD; Moore RL; Nakagawa Y; Yokomuro K; Fox BS; Margulies DH
    J Immunol; 1995 Feb; 154(4):1973-86. PubMed ID: 7530749
    [TBL] [Abstract][Full Text] [Related]  

  • 29. EpiTOP--a proteochemometric tool for MHC class II binding prediction.
    Dimitrov I; Garnev P; Flower DR; Doytchinova I
    Bioinformatics; 2010 Aug; 26(16):2066-8. PubMed ID: 20576624
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ab initio prediction of peptide-MHC binding geometry for diverse class I MHC allotypes.
    Bordner AJ; Abagyan R
    Proteins; 2006 May; 63(3):512-26. PubMed ID: 16470819
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A molecular basis for how a single TCR interfaces multiple ligands.
    Boesteanu A; Brehm M; Mylin LM; Christianson GJ; Tevethia SS; Roopenian DC; Joyce S
    J Immunol; 1998 Nov; 161(9):4719-27. PubMed ID: 9794402
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A polymorphic pocket at the P10 position contributes to peptide binding specificity in class II MHC proteins.
    Zavala-Ruiz Z; Strug I; Anderson MW; Gorski J; Stern LJ
    Chem Biol; 2004 Oct; 11(10):1395-402. PubMed ID: 15489166
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Alloreactive T cell recognition of MHC class I molecules: the T cell receptor interacts with limited regions of the MHC class I long alpha helices.
    Smith KD; Lutz CT
    J Immunol; 1997 Mar; 158(6):2805-12. PubMed ID: 9058816
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MUC1 peptide epitopes associated with five different H-2 class I molecules.
    Apostolopoulos V; Haurum JS; McKenzie IF
    Eur J Immunol; 1997 Oct; 27(10):2579-87. PubMed ID: 9368613
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Energetics and cooperativity of the hydrogen bonding and anchor interactions that bind peptides to MHC class II protein.
    McFarland BJ; Katz JF; Sant AJ; Beeson C
    J Mol Biol; 2005 Jul; 350(1):170-83. PubMed ID: 15921691
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Quantitative analysis of peptide-MHC class II interaction.
    Fleckenstein B; Jung G; Wiesmüller KH
    Semin Immunol; 1999 Dec; 11(6):405-16. PubMed ID: 10625594
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Contrasting efficacy of presentation by major histocompatibility complex class I and class II products when peptides are administered within a common protein carrier, self immunoglobulin.
    Zaghouani H; Kuzu Y; Kuzu H; Brumeanu TD; Swiggard WJ; Steinman RM; Bona CA
    Eur J Immunol; 1993 Nov; 23(11):2746-50. PubMed ID: 8223850
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Peptide binding to HLA-DP proteins at pH 5.0 and pH 7.0: a quantitative molecular docking study.
    Patronov A; Dimitrov I; Flower DR; Doytchinova I
    BMC Struct Biol; 2012 Aug; 12():20. PubMed ID: 22862845
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of Structural Observables From Simulations to Predict the Effect of Single-Point Mutations in MHC Class II Peptide Binders.
    Ochoa R; Laskowski RA; Thornton JM; Cossio P
    Front Mol Biosci; 2021; 8():636562. PubMed ID: 34222328
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HLA-DP2 binding prediction by molecular dynamics simulations.
    Doytchinova I; Petkov P; Dimitrov I; Atanasova M; Flower DR
    Protein Sci; 2011 Nov; 20(11):1918-28. PubMed ID: 21898654
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.